Journal of Hypertension • Vol 42 • No 11
The components of arginine and methylarginine metabolism are indicative of altered kidney function in intrauterine growth-restricted neonates
August 2024 • Lina Kleinebenne, Waldemar Röhrig, Fabian Ebach, Heiko Reutter, Alexander Pankraz, Katharina Monika Heuchel, Andreas Müller, Alina C. Hilger
Background: Intrauterine fetal growth restriction (IUGR) affects up to 10% of all pregnancies. Severe IUGR is associated with impaired kidney development, reduced nephron endowment, and chronic kidney disease later in life. Currently, no early predictive biomarker exists for detecting altered kidney function in neonates with IUGR. Because nephrons produce key enzymes for the metabolism of arginine and methylarginine components, we quantified and compared the concentrations of arginine and methylarginine metabolite…